Gastric precancerous lesions in two low risk populations: cross-country comparison
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S77-S78
DOI: 10.1055/s-0046-1820762 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von N Kapteyn und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Gastric cancer (GC) is a leading cause of cancer-related mortality, with premalignant lesions (PGLs) like gastric intestinal metaplasia (GIM) and dysplasia acting as key precursors. While surveillance is recommended, risk factors and progression rates in low-incidence regions remain underexplored. This study evaluates progression risk of patients with PGL in the Netherlands and Spain, both low GC incidence countries.
Methods
Patients were recruited from the Progression and Regression of Gastric Lesions study (PROREGAL MEC-2009-090) in the Netherlands consisting of eight hospitals and Hospital Clínic de Barcelona, Spain. Eligible participants were under surveillance for GIM or dysplasia and had at least one follow-up endoscopy, with biopsies taken from standardized sites, between 2009 and 2025. Patient demographics, lifestyle factors, and clinical data were collected through standardized questionnaires and the electronic medical record. GIM stage was assessed using the OLGIM (Operative Link on Gastric Intestinal Metaplasia) staging system, and GIM progression was based on the increase in OLGIM. The primary outcome was annual neoplastic progression to high-grade dysplasia (HGD) or intramucosal cancer (IMC), with secondary outcomes including progression to any type of dysplasia and OLGIM progression rate. Surveillance was performed following the MAPS guideline. Statistical analyses included Chi-squared tests for categorical variables and t-tests for continuous variables between cohorts ([ Table 1 ]). Table 1 OLGIM and neoplastic progression outcomes in Dutch and Spanish cohorts The Netherlands (n=321) Spain (n=90) OLGIM progression (yes), n (%) 95 (29.6) 26 (28.9) Neoplastic progression (yes), n (%) 12 (3.8) 8 (8.9) LGD, n (%) 3 (0.9) 7 (7.8) HGD, n (%) 6 (1.9) 0 (0.0) IMC, n (%) 3 (0.9) 1 (1.1)
Results
A total of 414 patients were enrolled in this study, 312 from the Netherlands and 90 from Spain with a median follow-up time of 50 and 37 months. The median age at index of the Dutch cohort was 59 years (SD 13) vs 64 years (SD 11) in the Spanish cohort (p=0.001). The Dutch cohort had a higher proportion of males (54.2% vs 34.4%, p=0.001). Smoking (29.3% vs 15.6%, p=0.007) and alcohol use ( 53.9% vs 11.1%, p
Zitieren
APA
Kapteyn, N., Scheid, I. L., Cantú-Germano, E., Ruiz, L. M., Holster, I. L., Capelle, L. G., Schot, I., Anten, M. P., Witteman, E., Borg, F. T., Burger, J., Doukas, M., Kuipers, E. J., Honing, J., & Spaander, M. (2026). Gastric precancerous lesions in two low risk populations: cross-country comparison. Endoscopy, 58(S 03 S 03), S77-S78. https://doi.org/10.1055/s-0046-1820762
Vancouver
Kapteyn N, Scheid IL, Cantú-Germano E, Ruiz LM, Holster IL, Capelle LG, et al. Gastric precancerous lesions in two low risk populations: cross-country comparison. Endoscopy. 2026;58(S 03 S 03):S77-S78. doi:10.1055/s-0046-1820762
BibTeX
@article{Kapteyn2026,
author = {Kapteyn, N and Scheid, I Luzko and Cantú-Germano, E and Ruiz, L Moreira and Holster, I L and Capelle, L G and Schot, I and Anten, M P and Witteman, E and Borg, F Ter and Burger, J and Doukas, M and Kuipers, E J and Honing, J and Spaander, M},
title = {Gastric precancerous lesions in two low risk populations: cross-country comparison},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S77--S78},
doi = {10.1055/s-0046-1820762}
}
EUVIMED